{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "57237-313",
      "generic_name": "Dextromethorphan HBr. and Guaifenesin",
      "labeler_name": "Rising Pharma Holdings, Inc.",
      "brand_name": "Dextromethorphan HBr. and Guaifenesin",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/10mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "57237-313-18",
          "description": "80 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (57237-313-18)  / 10 mL in 1 CUP, UNIT-DOSE (57237-313-01)",
          "marketing_start_date": "20230612",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION",
      "spl_id": "6c9e7e2a-5fb7-4e1b-813e-d0ab33a43502",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230612",
      "product_id": "57237-313_6c9e7e2a-5fb7-4e1b-813e-d0ab33a43502",
      "application_number": "M012.85",
      "brand_name_base": "Dextromethorphan HBr. and Guaifenesin",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}